SITC Cancer Immunotherapy CONNECT

SITC Statement on NIH Cuts to Indirect Costs

Browse our other events




2025 ACI Gastrointestinal

2025 ACI: A Focus on Gastrointestinal Cancers

April 23, 2025 | 1–5 p.m. EDT | Virtual

Discuss recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers. Improve patient outcomes with cutting-edge insights from clinical experts!

Register now
Lunit

Lunit Research Program

Exclusively for SITC Members | Applications due April 30

This Lunit research program aims to enhance studies led by SITC members by enabling the use of AI for TME profiling, including quantitative immune phenotyping (IP) via three IP classification: inflamed, excluded and desert.

Learn more
2025 ACI

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines!

Register now
2025 Deep Dive

Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology

May 8 | 2:15–3:45 p.m. ET | Virtual

Explore how these guidelines and best practices can shape the future of clinical trials and drive progress in immunotherapy!

Register Now


2025 Deep Dive

A Deep Dive into T-cell Engagers and Targeted Immune Modulation for Prostate Cancer

May 12 | 11 a.m.–1 p.m. ET | Virtual

This webinar will address lessons learned from past studies of T cell engagers and immune modulators for solid tumors and how these insights have informed the identification and testing of these therapies.

Register Now


2025 ACI

2025 ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies

June 27, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies. 

Register now

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

JITC Digest April 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...

JITC Digest April 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...

 Latest Discussions

  • 2025 SITC Fellowships

    Posted in: Women in SITC

    Hello, I'm excited to share with you that we recently launched the 2025 ...

  • NCI Virtual Workshop - In Vivo Engineering of Immune Cells ( IVEIC ) for Cancer ...

    3 people like this.
  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family